Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
TCR² Therapeutics history
TCR² Therapeutics company history timeline
Doctor Allen is a co-founder of Gritstone Oncology, Inc. (NASDAQ:GRTS), and has served as its President, Chief Executive Officer, and board member since its inception in August 2015.
Doctor Menzel joined TCR² in 2016 as a Director and Chief Executive Officer.
Turkowiak joined TCR² in 2017 as Vice President of Finance.
TCR² Cares is an employee-initiated program established in 2017 that focuses on giving back to our community in ways that connect to our corporate goal of curing cancer.
Siegel joined TCR² in 2018 as Head of Legal.
Doctor Justice joined TCR² in 2019 as Chief People Officer.
Check out our fundraising page for the 2019 Boston Marathon® Jimmy Fund Walk for Dana-Farber Cancer Institute
Muzithras joined TCR² in 2020 as Vice President of Regulatory Affairs.
Russell joined TCR² in 2021 as Vice President of Quality.
Doctor Harrison joined TCR2 in 2022 as Chief Business and Strategy Officer.
Rate how well TCR² Therapeutics lives up to its initial vision.
TCR² Therapeutics jobs
Do you work at TCR² Therapeutics?
Does TCR² Therapeutics communicate its history to new hires?
TCR² Therapeutics competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Eureka Therapeutics | 2006 | $500,000 | 50 | - |
| BioTime | 1990 | $3.4M | 101 | - |
| Allogene Therapeutics | 2017 | $95,000 | 289 | 3 |
| C4 Therapeutics | 2015 | $35.6M | 300 | 1 |
| Leap Therapeutics | 2011 | $1.5M | 30 | - |
| Adaptimmune | 2008 | $178.0M | 452 | - |
| Arcellx | 2015 | $107.9M | 1 | 56 |
| WindMIL Therapeutics | 2015 | $530,000 | 30 | - |
| Arvinas Inc. | 2013 | $263.4M | 83 | 10 |
TCR² Therapeutics history FAQs
Zippia gives an in-depth look into the details of TCR² Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about TCR² Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at TCR² Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by TCR² Therapeutics. The data presented on this page does not represent the view of TCR² Therapeutics and its employees or that of Zippia.
TCR² Therapeutics may also be known as or be related to TCR2, TCR2 THERAPEUTICS INC., TCR2 Therapeutics Inc., TCR² Therapeutics and Tcr2 Therapeutics Inc.